MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Components

The MVIS US Listed Biotech 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
MODERNA INCUS10.12%
AMGEN INCUS8.01%
GILEAD SCIENCES INCUS5.75%
IQVIA HOLDINGS INCUS5.54%
REGENERON PHARMACEUTICALSUS5.32%
VERTEX PHARMACEUTICALS INCUS5.31%
ICON PLCIE5.21%
BIONTECH SEDE5.15%
SEAGEN INCUS4.46%
ILLUMINA INCUS4.42%
BIOGEN INCUS4.18%
BIO-TECHNE CORPUS4.04%
CHARLES RIVER LABORATORIESUS3.97%
NOVAVAX INCUS3.55%
BEIGENE LTD-ADRKY3.21%
ALNYLAM PHARMACEUTICALS INCUS3.05%
EXACT SCIENCES CORPUS2.92%
QIAGEN NVNL2.89%
GUARDANT HEALTH INCUS2.46%
BIOMARIN PHARMACEUTICAL INCUS2.28%
INCYTE CORPUS2.01%
NATERA INCUS1.94%
10X GENOMICS INCUS1.68%
INTELLIA THERAPEUTICS INCUS1.32%
CRISPR THERAPEUTICS AGCH1.21%
Items 1-25 of total 25
Up